본문 바로가기
KERD
논문KCI 등재

Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류피부과학

초록

Background: Patients with recessive dystrophic epidermolysis bullosa (RDEB) exhibit blisters and erosions since birth, causing pain, pruritus and various complications. RDEB affects quality of life (QoL) in physical, emotional and social aspects. Furthermore, interminable dressing changes and supportive therapies impose a significant economic burden on the patient’s family. Objective: We assessed the QoL and economic burden in patients with RDEB. Methods: Sixteen patients with RDEB were surveyed to assess the QoL and economic burden. Patients answered questionnaires consisting of a visual analogue scale (VAS) on pain and pruritus, Skindex-29, Quality of Life in EB questionnaire (QOLEB), and the economic burden due to EB. Results: Thirteen patients with RDEB completed the questionnaire. Female patients presented higher VAS, QOLEB and total Skindex-29 scores than male patients. Patients with RDEB showed severe levels of pruritus, which was more intolerable than pain. Mean VAS score on pain in RDEB was higher than in oral lichen planus and post-herpetic neuralgia. VAS score on pruritus was similar to those in chronic urticaria, atopic dermatitis, and prurigo nodularis. Compared with other dermatologic conditions, patients with RDEB were profoundly affected in all three scales of skindex-29. Mean “medical cost” in a month was $257.54 (USD) (±169.39) and mean “dressing cost” was $358.41 (USD) (±312.55), which was negatively related to patient age. Conclusion: RDEB had a profound impact on QoL and economic burden. Compared with other dermatologic diseases, RDEB showed severe symptoms and QoL was seriously impaired. Most patients sustained economic burdens, especially on preparing dressing materials. Younger patients experienced more economic burdens.

Abstract

Background: Patients with recessive dystrophic epidermolysis bullosa (RDEB) exhibit blisters and erosions since birth, causing pain, pruritus and various complications. RDEB affects quality of life (QoL) in physical, emotional and social aspects. Furthermore, interminable dressing changes and supportive therapies impose a significant economic burden on the patient’s family. Objective: We assessed the QoL and economic burden in patients with RDEB. Methods: Sixteen patients with RDEB were surveyed to assess the QoL and economic burden. Patients answered questionnaires consisting of a visual analogue scale (VAS) on pain and pruritus, Skindex-29, Quality of Life in EB questionnaire (QOLEB), and the economic burden due to EB. Results: Thirteen patients with RDEB completed the questionnaire. Female patients presented higher VAS, QOLEB and total Skindex-29 scores than male patients. Patients with RDEB showed severe levels of pruritus, which was more intolerable than pain. Mean VAS score on pain in RDEB was higher than in oral lichen planus and post-herpetic neuralgia. VAS score on pruritus was similar to those in chronic urticaria, atopic dermatitis, and prurigo nodularis. Compared with other dermatologic conditions, patients with RDEB were profoundly affected in all three scales of skindex-29. Mean “medical cost” in a month was $257.54 (USD) (±169.39) and mean “dressing cost” was $358.41 (USD) (±312.55), which was negatively related to patient age. Conclusion: RDEB had a profound impact on QoL and economic burden. Compared with other dermatologic diseases, RDEB showed severe symptoms and QoL was seriously impaired. Most patients sustained economic burdens, especially on preparing dressing materials. Younger patients experienced more economic burdens.

참고문헌 (25)

  1. Fine JD., "Inherited epidermolysis bullosa : updated recommendations on diagnosis and classification", J Am Acad Dermatol, 70, pp.1103~1126 (2014)
  2. van Scheppingen C., "Main problems experienced by children with epidermolysis bullosa : a qualitative study with semi-structured interviews", Acta Derm Venereol, 88, pp.143~150 (2008)
  3. Frew JW., "Quality of life measurements in epidermolysis bullosa : tools for clinical research and patient care", Dermatol Clin, 28, pp.185~190 (2010)
  4. Frew JW., "Quality of life evaluation in epidermolysis bullosa(EB)through the development of the QOLEB questionnaire : an EB-specific quality of life instrument", Br J Dermatol, 161, pp.1323~1330 (2009)
  5. Tabolli S., "Quality of life in patients with epidermolysis bullosa", Br J Dermatol, 161, pp.869~877 (2009)
  6. Wagner JE., "Bone marrow transplantation for recessive dystrophic epidermolysis bullosa", N Engl J Med, 363, pp.629~639 (2010)
  7. Conget P., "Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa", Cytotherapy, 12, pp.429~431 (2010)
  8. Pagliarello C., "Factors affecting quality of life in epidermolysis bullosa", Expert Rev Pharmacoecon Outcomes Res, 10, pp.329~338 (2010)
  9. Lundqvist C., "A vertical VAS is a valid instrument for monitoring headache pain intensity", Cephalalgia, 29, pp.1034~1041 (2009)
  10. Reich A., "Visual analogue scale : evaluation of the instrument for the assessment of pruritus", Acta Derm Venereol, 92, pp.497~501 (2012)
  11. Mansourian A., "Comparison of aloe vera mouthwash with triamcinolone acetonide0.1% on oral lichen planus: a randomized double-blinded clinical trial", Am J Med Sci, 342, pp.447~451 (2011)
  12. Park J., "Thermography as a predictor of postherpetic neuralgia in acute herpes zoster patients : a preliminary study", Skin Res Technol, 18, pp.88~93 (2012)
  13. Aydogan K., "Narrowband ultraviolet B(311 nm, TL01)phototherapy in chronic ordinary urticaria", Int J Dermatol, 51, pp.98~103 (2012)
  14. Chrostowska-Plak D., "Relationship between itch and psychological status of patients with atopic dermatitis", J Eur Acad Dermatol Venereol, 27, pp.e239~e242 (2013)
  15. Ständer S., "Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy", PLoS One, 5, pp.e10968~ (2010)
  16. Arenberger P., "Effect of topical heparin and levomenol on atopic dermatitis : a randomized four-arm, placebo-controlled, double-blind clinical study", J Eur Acad Dermatol Venereol, 25, pp.688~694 (2011)
  17. Nijsten T, "Dermatology life quality index : time to move forward", J Invest Dermatol, 132, pp.11~13 (2012)
  18. 안봉균, "피부과 환자의 삶의 질 평가를 위한 한국어판 Skindex-29", 대한피부과학회지, 42(1), pp.9~15 (2004), 대한피부과학회
  19. 안봉균, "여드름 환자의 삶의 질 조사", 대한피부과학회지, 43(1), pp.6~14 (2005), 대한피부과학회
  20. Ryu JH., "Quality of life in patients with psoriasis", Korean J Dermatol, 42, pp.264~271 (2004)
  21. Sung Hyub Han, "Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study", Annals of Dermatology, 24(3), pp.311~318 (2012), 대한피부과학회[DOI]
  22. Klein R., "Quality of life in cutaneous lupus erythematosus", J Am Acad Dermatol, 64, pp.849~858 (2011)
  23. Sampogna F., "Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions", Psychosom Med, 66, pp.620~624 (2004)
  24. Fine JD., "Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa", Clin Exp Dermatol, 29, pp.122~127 (2004)
  25. Pope E., "A consensus approach to wound care in epidermolysis bullosa", J Am Acad Dermatol, 67, pp.904~917 (2012)

관련 논문AI추천

이 간행물의 다른 논문 (32건)